Tau Stabilizes Chromatin Compaction
Type de document :
Article dans une revue scientifique: Article original
PMID :
Titre :
Tau Stabilizes Chromatin Compaction
Auteur(s) :
Rico, Thomas [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Gilles, Melissa [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Chauderlier, Alban [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Comptdaer, Thomas [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Magnez, Romain [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Chwastyniak, Maggy [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Drobecq, Herve [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
PINET, FLORENCE [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Thuru, Xavier [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Buee, Luc [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Galas, Marie-Christine [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Lefebvre, Bruno [Auteur correspondant]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Gilles, Melissa [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Chauderlier, Alban [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Comptdaer, Thomas [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Magnez, Romain [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Chwastyniak, Maggy [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Drobecq, Herve [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
PINET, FLORENCE [Auteur]

Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Thuru, Xavier [Auteur]

Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Buee, Luc [Auteur]

Lille Neurosciences & Cognition - U 1172 [LilNCog]
Galas, Marie-Christine [Auteur]

Lille Neurosciences & Cognition - U 1172 [LilNCog]
Lefebvre, Bruno [Auteur correspondant]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Titre de la revue :
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Pagination :
740550
Éditeur :
Frontiers media
Date de publication :
2021-10-14
ISSN :
2296-634X
Mot(s)-clé(s) en anglais :
Tau protein (Tau)
chromatin remodeling
chromatin regulation
histone modification and chromatin structure
histone deacetylase inhibitor (HDAC inhibitor)
histone (de)acetylation
cancer biology
chromatin remodeling
chromatin regulation
histone modification and chromatin structure
histone deacetylase inhibitor (HDAC inhibitor)
histone (de)acetylation
cancer biology
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
An extensive body of literature suggested a possible role of the microtubule-associated protein Tau in chromatin functions and/or organization in neuronal, non-neuronal, and cancer cells. How Tau functions in these processes ...
Lire la suite >An extensive body of literature suggested a possible role of the microtubule-associated protein Tau in chromatin functions and/or organization in neuronal, non-neuronal, and cancer cells. How Tau functions in these processes remains elusive. Here we report that Tau expression in breast cancer cell lines causes resistance to the anti-cancer effects of histone deacetylase inhibitors, by preventing histone deacetylase inhibitor-inducible gene expression and remodeling of chromatin structure. We identify Tau as a protein recognizing and binding to core histone when H3 and H4 are devoid of any post-translational modifications or acetylated H4 that increases the Tau’s affinity. Consistent with chromatin structure alterations in neurons found in frontotemporal lobar degeneration, Tau mutations did not prevent histone deacetylase-inhibitor-induced higher chromatin structure remodeling by suppressing Tau binding to histones. In addition, we demonstrate that the interaction between Tau and histones prevents further histone H3 post-translational modifications induced by histone deacetylase-inhibitor treatment by maintaining a more compact chromatin structure. Altogether, these results highlight a new cellular role for Tau as a chromatin reader, which opens new therapeutic avenues to exploit Tau biology in neuronal and cancer cells.Lire moins >
Lire la suite >An extensive body of literature suggested a possible role of the microtubule-associated protein Tau in chromatin functions and/or organization in neuronal, non-neuronal, and cancer cells. How Tau functions in these processes remains elusive. Here we report that Tau expression in breast cancer cell lines causes resistance to the anti-cancer effects of histone deacetylase inhibitors, by preventing histone deacetylase inhibitor-inducible gene expression and remodeling of chromatin structure. We identify Tau as a protein recognizing and binding to core histone when H3 and H4 are devoid of any post-translational modifications or acetylated H4 that increases the Tau’s affinity. Consistent with chromatin structure alterations in neurons found in frontotemporal lobar degeneration, Tau mutations did not prevent histone deacetylase-inhibitor-induced higher chromatin structure remodeling by suppressing Tau binding to histones. In addition, we demonstrate that the interaction between Tau and histones prevents further histone H3 post-translational modifications induced by histone deacetylase-inhibitor treatment by maintaining a more compact chromatin structure. Altogether, these results highlight a new cellular role for Tau as a chromatin reader, which opens new therapeutic avenues to exploit Tau biology in neuronal and cancer cells.Lire moins >
Langue :
Anglais
Comité de lecture :
Oui
Audience :
Internationale
Vulgarisation :
Non
Projet ANR :
Source :
Fichiers
- https://hal.archives-ouvertes.fr/hal-03429442/document
- Accès libre
- Accéder au document
- https://hal.archives-ouvertes.fr/hal-03429442/document
- Accès libre
- Accéder au document
- document
- Accès libre
- Accéder au document
- fcell-09-740550.pdf
- Accès libre
- Accéder au document
- Accès libre
- Accéder au document
- document
- Accès libre
- Accéder au document
- fcell-09-740550.pdf
- Accès libre
- Accéder au document